Mednet Logo

What RT dose/fractionation would you use to treat an unresectable grade 3 solitary fibrous tumor abutting the optic nerve and chiasm?

4 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Columbia University Irving Medical Center
Answered on · Updated on

Generally, I would consider treating an unresectable grade 3 solitary fibrous tumor to up to 59.4/60 Gy, or possibly higher. The location of this tumor makes it difficult to treat entirely using this dose while respecting the optic nerve/chiasm constraints. How is the patient's vision? If intact, op...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · The Ohio State University - James Cancer Hospital and Solove Research Institute
Answered on · Updated on

From a non-CNS sarcoma standpoint, there is published European experience with definitive-intent RT for unresected SFT, and a clear dose-response relationship, with ~80% local control at 60+ Gy vs ~30% at lower palliative doses. Thus, trying to get as much of the tumor to a definitive dose, while re...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Texas MD Anderson Cancer Center
Answered on

There isn't a perfect answer for this case, but we would consider 59.4 Gy-60 Gy in 1.8 Gy/2 Gy and maintain optic constraint of ~54 Gy abutting it and use ExacTrac/IGRT to be able to treat within 1 mm (i.e., let the constraint drive coverage). Interestingly, I also polled our sarcoma group, and a co...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · University of Arkansas for Medical Sciences
Answered on

Before launching into XRT for this CNS patient, I would review with Sarcoma Med Onc regarding initial treatment with an antiangiogenic agent. SFTs have a relatively high rate of PR with those agents, which might provide some extra room for working around the visual apparatus. If embarking on that ap...

Join for free or sign in to see the full answer